Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 21% ± 3% | |
B cell | 3 studies | 24% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 20% ± 6% | |
endothelial cell | 3 studies | 19% ± 2% | |
oligodendrocyte | 3 studies | 23% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2071.36 | 245 / 245 | 100% | 10.67 | 501 / 502 |
thymus | 100% | 2996.00 | 653 / 653 | 100% | 17.92 | 603 / 605 |
breast | 100% | 1996.40 | 459 / 459 | 100% | 11.51 | 1114 / 1118 |
ovary | 100% | 2909.16 | 180 / 180 | 100% | 7.76 | 428 / 430 |
uterus | 100% | 1723.13 | 170 / 170 | 99% | 10.42 | 455 / 459 |
kidney | 100% | 1481.63 | 89 / 89 | 99% | 11.16 | 892 / 901 |
bladder | 100% | 1752.52 | 21 / 21 | 99% | 9.20 | 498 / 504 |
brain | 99% | 1082.55 | 2610 / 2642 | 100% | 11.94 | 705 / 705 |
lung | 100% | 1852.87 | 577 / 578 | 99% | 10.31 | 1143 / 1155 |
skin | 100% | 1852.28 | 1809 / 1809 | 99% | 9.72 | 465 / 472 |
stomach | 100% | 1200.48 | 359 / 359 | 97% | 6.45 | 276 / 286 |
liver | 100% | 1357.76 | 226 / 226 | 96% | 7.07 | 390 / 406 |
intestine | 100% | 1819.95 | 966 / 966 | 96% | 6.74 | 505 / 527 |
adrenal gland | 100% | 1424.79 | 258 / 258 | 96% | 7.30 | 220 / 230 |
esophagus | 100% | 1679.35 | 1445 / 1445 | 96% | 8.19 | 175 / 183 |
pancreas | 96% | 656.05 | 316 / 328 | 98% | 9.59 | 175 / 178 |
adipose | 100% | 1629.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.17 | 29 / 29 |
spleen | 100% | 2469.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.53 | 1 / 1 |
blood vessel | 100% | 1410.07 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1274.71 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1339.48 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 7.13 | 74 / 80 |
peripheral blood | 92% | 1008.74 | 851 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006338 | Biological process | chromatin remodeling |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005737 | Cellular component | cytoplasm |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | ZNF274 |
Protein name | Zinc finger protein 274 Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2) (Zf2) |
Synonyms | ZKSCAN19 SP2114 |
Description | FUNCTION: Probable transcription repressor. Specifically binds to the 3'-end of zinc-finger coding genes and recruiting chromatin-modifying proteins such as SETDB1 and TRIM28/KAP1, leading to transcription repression. The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions . . |
Accessions | ENST00000326804.8 ENST00000617501.5 [Q96GC6-1] ENST00000424679.6 [Q96GC6-3] M0QXW4 ENST00000345813.7 [Q96GC6-2] ENST00000597528.1 ENST00000594839.5 Q96GC6 A0A0A0MR47 M0QY30 ENST00000610905.4 [Q96GC6-1] |